LivaNova completed the acquisition of the remaining 97% stake in ALung Technologies for $10m.

Synopsis

LivaNova, a medical device manufacturer, completed the acquisition of the remaining 97% stake in ALung Technologies, a medical device company, for $10m.

Principals

target

Alung Technologies

bidder

Livanova

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (1)

peter decomo

CEO at ALUNG TECHNOLOGIES

Manager

target

Deal

£ 8 M

Total Value

Bidder Team (1)

damien mcdonald

CEO at LIVANOVA PLC

Manager

bidder

Deals

£ 59 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy